SDG 3: Good Health and Well-being | SDG 17: Partnerships for the Goals
Institutions: Ministry of Health & Family Welfare | Department of Health Research
On 18 November 2025, the Ministry of Health & Family Welfare launched the updated National Action Plan on Antimicrobial Resistance (NAP AMR) 2.0 for the period 2025-29, highlighting the growing threat of antimicrobial resistance (AMR) to surgical procedures, cancer treatment and overall public-health outcomes.
The plan emphasises a “One Health” approach — encompassing human health, animal health, agriculture and environment sectors. It mandates stronger inter-sectoral coordination, greater private-sector engagement, enhanced laboratory capacity, infection-control protocols in health-care facilities, and improved awareness, education and training across stakeholders.
State-level actions such as banning over-the-counter antibiotics (Kerala and Gujarat cited) and establishing the India AMR Innovation Hub to foster R&D and innovation in AMR containment were also highlighted.
The escalation of AMR is a critical threat to India’s health-care system, potentially reversing decades of progress in infectious disease control and modern medicine. By launching this updated plan, the Ministry strengthens its integration with the national health infrastructure, the National Health Policy, and global commitments under the Global Action Plan on AMR. It also offers a clear framework for multi-sector action, signalising to private industry, research institutes and states that AMR is a national priority.
What is Antimicrobial Resistance (AMR)?→ AMR occurs when microorganisms (bacteria, viruses, fungi, parasites) evolve to resist standard treatments, making infections harder to treat, increasing risk of disease spread, and raising health-care costs and mortality.
Relevant Question for Policy Stakeholders: How will the coordination across human-animal-environment sectors be structured to ensure the NAP AMR 2.0 is translated into measurable outcomes
Follow the full news here: National Action Plan on Antimicrobial Resistance (2025–29)